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Abstract 
Cryptococcus neoformans infections are a major cause of meningoencephalitis in 
immunosuppressed patients worldwide. Inhaled as spores or desiccated yeast cells, C. neoformans 
can undergo metabolic changes in response to the new host environment that allow it to cross the 
blood brain barrier and cause deadly central nervous system (CNS) infections. Nutrient 
acquisition, and specifically carbon metabolism, is critical for survival and proliferation within 
the host. Notably, efficient carbon metabolism is necessary to produce the polysaccharide 
capsule, which is arguably C. neoformans’ most important and well-studied virulence factor. As 
such, a better understanding of carbon acquisition and regulation is essential for the development 
of new targeted drug therapies to combat this deadly fungus.  
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The Essential Role of Carbon Metabolism in the Virulence of Cryptococcus neoformans 
Introduction 
The Cryptococcus neoformans species complex is comprised of unicellular 
encapsulated fungi that can replicate by budding and share many general characteristics 
with Saccharomyces cerevisiae (Aslanyan et al., 2017). An obligate aerobe most often 
isolated from avian fecal matter, C. neoformans is a common environmental fungus 
found worldwide. Cryptococcal spores are commonly present in the air, and the vast 
majority of individuals are frequently exposed to this fungus throughout life (Goldman et 
al., 2001). In healthy individuals, a functioning immune system is able to effectively 
eliminate spores and yeasts prior to onset of disease with near perfect efficiency.  
Cryptococcosis: An Opportunistic Infection 
While C. neoformans rarely causes long-term complications or systemic disease 
in immunocompetent individuals, it occasionally results in fungal pneumonia that is 
resolved by a functioning immune system. However, cryptococcal infections (i.e. 
cryptococcosis) are a leading cause of meningoencephalitis in immunosuppressed 
patients worldwide (Dambuza et al., 2018). The highest incidence of disease occurs 
among individuals with HIV/AIDS, largely due to the lack of CD4+ T-helper cells present 
in the bloodstream. However, any immunocompromised individual can develop 
cryptococcosis, with at-risk groups including chemotherapy patients, transplant recipients 
on immunosuppressive anti-rejection medications, and individuals on chronic 
corticosteroids for autoimmune disorders (Lin, Huang, Mitchell, & Heitman, 2006). 
Seven species of Cryptococcus can cause disease, though C. neoformans is the most 
clinically significant strain with effects ranging from localized cutaneous infections to 
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widespread systemic disease (Hagen et al., 2015). C. neoformans is invasive and difficult 
to treat, largely due to its ability to cross the blood brain barrier and cause CNS 
infections. Antifungal drug options are limited and expensive, and while widely available 
in developed nations, these medications often pose harmful side effects (Fernandes, 
Martho, Tofik, Vallim, & Pascon, 2015). It is estimated that over 223,000 individuals 
contract cryptococcal meningitis annually, with prognosis highly dependent on access to 
sophisticated medical care (Rajasingham et al., 2017). As the epidemiology of this 
disease is closely linked to the AIDS pandemic, the vast majority of cases are 
concentrated in sub-Saharan Africa due to the lack of antiretroviral therapy available to 
patients. Because of its mortality of greater than 50%, scientists are continually working 
towards a better understanding of C. neoformans in order to develop new treatments to 
combat this disease (Rajasingham et al., 2017).  
Pathogenesis 
Due to the body’s natural immune response, individuals with functioning immune 
systems are generally able to fend off C. neoformans infections prior to systemic disease 
progression. Studies have shown that immunosurveillance in healthy individuals is very 
effective, with respiratory epithelial cells playing a critical role. These cells are separated 
by tight junctions, which helps to provide a physical barrier against invading microbes 
(Whitsett & Alenghat, 2015). In addition, T-helper 1 (Th1) cells are crucial because they 
mediate a protective immune response through the production of various cytokines. 
Specific cell-signaling cytokines that play a role in response against C. neoformans 
include interleukin-2 (IL-2), IL-12, interferon gamma, and tumor necrosis factor alpha 
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that are produced initially by dendritic cells and macrophages (Whitsett & Alenghat, 
2015). While important molecules and proteins have been isolated, the exact mechanism 
of this response is still an active area of study.  
In immunosuppressed hosts, the ability of C. neoformans to disseminate 
systemically before infection is eradicated by the immune response causes serious, and 
often fatal, disease processes. While this fungus can travel to diverse locations within the 
body, it has a particular affinity for the CNS. Studies have shown that there are two main 
pathways for C. neoformans dissemination: the intracellular mechanism and extracellular 
mechanism (Denham & Brown, 2018). 
Intracellular mechanism. The intracellular mechanism of C. neoformans 
dissemination uses the machinery of migratory phagocytes, most notably macrophages, to 
move from the lungs to other areas of the body. Ultimately, this method, also known as 
the Trojan Horse mechanism, allows the fungal spores to enter into macrophages, where 
they germinate into yeasts that are carried into the CNS (Charlier et al., 2009; Tseng, et 
al., 2012). Spores or desiccated cells contact macrophages and dendritic cells in the 
mucosal layers of the lungs. These macrophages, which can control the infection in 
healthy individuals, inadvertently facilitate the spread of disease in immunosuppressed 
hosts. The mechanism is three-fold. First, C. neoformans is engulfed by alveolar 
macrophages in the lungs (Denham & Brown, 2018; Bojarczuk et al., 2016). Because low 
CD4+ helper T cell counts delay the immune response, macrophages in 
immunosuppressed individuals are able to take up C. neoformans, but they have a very 
difficult time destroying them once they do so.  
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Secondly, the microbe must be able to survive within the macrophage or 
phagolysosome for an extended period, allowing enough time for travel to distant organs 
and body systems. Studies have shown that this is possible due to several key 
characteristics of C. neoformans. This fungus is able to survive at very low pH, which is 
essential to intracellular survival (Vogel, 1969). This adaptation likely stems from the 
fact that avian fecal matter, the primary environmental host of C. neoformans, is typically 
quite acidic. Unfortunately, C. neoformans is actually able to replicate slightly faster 
when it is an acidic environment, making it even more difficult to eliminate in 
macrophages (Diamond & Bennet, 1973). 
The third and final step in intracellular disease progression is the macrophage 
escape process (Tucker & Casadevall, 2002). In simple terms, C. neoformans is able to 
increase the permeability of the macrophage/phagolysosome by altering phospholipase 
expression in order to increase permeability; this is accomplished either by physical 
disruption of membranes or via modulation of cell signaling pathways (Djordjevic, 
2010). At the same time, C. neoformans transiently alters the host actin network that has 
a structure resembling a cage. This cage-like apparatus is able to confine the phagosome, 
but it allows C. neoformans to exit via small gaps within the actin network (Johnston & 
May, 2010). This same mechanism can be used for lateral macrophage transfer or for 
escape during macrophage division or fusion (Johnston & May, 2010). Through a series 
of interrelated steps, the Trojan Horse method allows C. neoformans to enter the CNS 
and cause life-threatening meningitis.   
Extracellular mechanism. The second mechanism of disease dissemination is 
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primarily extracellular. It hinges on the process of transcytosis (Chang et al., 2004). 
Transcytosis uses vesicular transport to capture a particle or microbe on the luminal side 
of the cell, transport it through the interior of the cell, and release the particle on the basal 
side. In the case of inhaled C. neoformans, the organism travels through the epithelial 
cells of the respiratory tract before it is deposited into the bloodstream. From there, C. 
neoformans can travel systemically. GXM, the major polysaccharide in the capsule of C. 
neoformans, is directly responsible for this process (Wang, Aisen, & Casadevall, 1995). 
GXM mediates the adherence of C. neoformans to CD14, a protein found on the cell 
membrane of epithelial cells (Denham & Brown 2018). Once adhered, C. neoformans 
uses a separate mechanism to enter the epithelial cell and cause damage that allows the 
cell to pass through. To date, scientists are still determining the exact biochemical 
interactions that facilitate this process.  
Virulence Factors 
Among microorganisms, and pathogenic fungi in particular, there are several 
general indicators of virulence. Specifically for C. neoformans, capsule production, 
melanin production, and the temperature of the host all play a large role (Haynes et al., 
2011; Gomez & Nosanchuk, 2003). In a healthy individual, the front-line phagocytes, 
neutrophils, and dendritic cells of the innate immune response recognize and destroy 
cryptococcal cells. However, in immunosuppressed patients, these processes are 
impaired; in the setting of an inefficient or ineffective immune response, C. neoformans 
virulence factors prevent infection control and lead to widespread disease (Campuzano & 
Wormley, 2018).  
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Melanin production has long been recognized as a source of pathogenicity for 
opportunistic fungi such as C. neoformans (Gomez & Nosanchuk, 2003). This dark 
colored pigment is synthesized from a variety of biologic molecules, including some 
neurotransmitters (Wang & Casadevall, 1994). Because it is comprised of insoluble 
polymers, melanin cannot be easily degraded by macrophages in the host, making the 
immune system less effective against cells that produce it (Mednick, Nosanchuk, & 
Casadevall, 2005). As such, melanization plays a key role in protecting against 
degradative enzymes, and it has also been shown to protect against phagocytes and 
reactive oxygen species that are a part of the immune response (Wang & Casadevall, 
1994). 
            While melanin production is often used as a general indicator of fungal 
pathogenicity, capsule production is often regarded as the most important virulence factor 
for C. neoformans. The polysaccharide capsule, comprised of various polysaccharides, 
serves both offensive and defensive functions in the host environment (Agustinho, Miller, 
Li, & Doering, 2018).  In vivo, C. neoformans can also differentiate into larger titan cells, 
which have thicker polysaccharide capsules and contain a greater amount of chitin that 
provides increased strength and protection (Mukaremera et al., 2018). This external cell 
structure helps to modulate interactions between immune cells while protecting the yeast 
against phagocytic cells from the host (Garcia-Carnero, Perez-Garcia, Martinez-Alvarez, 
Reyes-Martinez, & Mora-Montes, 2018). As one of the most important indicators of 
virulence in C. neoformans, capsule production is often used as a marker in determining 
pathogenicity in experimental studies (Casadevall et al., 2018).  
THE ESSENTIAL ROLE OF CARBON METABOLISM 
 
10 
Carbon Metabolism in C. neoformans 
In order to cause disease in a host organism, a microbe must procure the basic 
building blocks of life from its surroundings. As a result, one of the largest challenges 
that any microbe faces is finding efficient metabolic strategies in a rapidly changing 
environment (Fernandes et al., 2015). Normally, C. neoformans lives in soil, decaying 
wood, and bird feces, where it can procure sufficient amounts of carbon and nitrogen 
from the environment (Barkal, Walsh, Botts, Beebe, & Hull, 2016). Because the ability to 
acquire and metabolize nutrients is directly related to a pathogen’s fitness in its respective 
environment, the metabolism of key nutrients, namely carbon, is required for virulence in 
C. neoformans (Ramachandra et al., 2014). Not a member of the normal human flora, C. 
neoformans typically enters the human host via inhalation of desiccated spores, where it 
must adapt its metabolic strategies prior to systemic dissemination and entry into the 
CNS (Diamond & Bennett, 1973) and (Guess et al., 2018).  
Understanding the metabolism of carbon has long been recognized as an 
important strategy for developing effective drug targets for specific organisms and 
disease processes. For example, it has been previously established that cancer cells rely 
on a functional glycolytic pathway in order to grow, as carbon metabolism allows the 
cells to proliferate and increase the tumor size (Vander Heiden, Cantley, & Thompson, 
2009). As such, researchers have begun to develop glycolysis inhibitors in order to target 
specific types of cancer cells and limit their growth. While glycolytic enzymes are nearly 
identical across species and cell types, the slight differences in nucleotide sequence 
provide potential species-specific targets for drug development. Not only is proliferation 
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essential to the progression of any malignant disease, but strong similarities are seen 
between neoplastic processes and eukaryotic pathogens during invasion (Vander Heiden 
et al., 2009). As such, understanding the complicated role of carbon metabolism in the 
pathogenesis of C. neoformans infections provides valuable insight into potential 
methods of disease treatment.  
Effects of a Changing Microenvironment  
 Throughout the pathogenesis of cryptococcosis, C. neoformans must adapt to a 
wide range of microenvironments in order to persist and cause disease within the host. As 
mentioned previously, C. neoformans lives and thrives in a diverse array of ecological 
settings, but it is most commonly isolated from decaying tree bark and soil containing 
avian fecal matter. In the environment, both atmospheric nitrogen and oxygen are 
abundant. Additional nutrients such as carbon are easily acquired from decomposing 
organic material in the soil. While C. neoformans is a known human pathogen and the 
majority of individuals are exposed to this relatively common fungus during childhood, it 
is not a member of the normal human flora (Perfect, 2006; Diamond & Bennet, 1973).  
Metabolism during early pulmonary infection. In addition to facilitating 
respiration and gas exchange within the human body, the lungs also provide a vital 
mucosal barrier that serves to protect against the millions of microbes that are found in 
the air at any given moment. Contact with such microbes is unavoidable, and C. 
neoformans is no exception (Denham & Brown, 2018). As such, cryptococcal infections 
generally start in the lungs through the inhalation of desiccated cells or spores. After the 
initial infection, spores can germinate into yeasts that disseminate throughout the body, 
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exist indefinitely as granulomas in the lungs, or they can be eradicated by the body’s 
immune response. 
 As the microenvironment of the mammalian lung is fundamentally different from 
the soil in which C. neoformans most commonly resides, this fungus must adapt to the 
changing availability of nutrients. While nitrogen and oxygen are still present in lung 
tissue, the availability of elemental carbon is significantly reduced compared to the 
external environment (Barelle et al., 2006). As such, C. neoformans alters the 
transcription of genes controlling carbon metabolism in a way that shifts the metabolic 
focus to the procurement of carbon from alternative sources. The glyoxylate shunt, citric 
acid cycle, and gluconeogenesis are all upregulated at the same time that glycolysis is 
downregulated (Barelle et al., 2006). While glycolysis is certainly the most efficient way 
to procure energy from environmental carbon, the upregulation of gluconeogenesis 
provides C. neoformans with an alternative carbon source that it can use in order to 
survive in the mammalian lung.  
Glycolysis and gluconeogenesis during early pulmonary infection. Present in all 
eukaryotic organisms, the glycolytic pathway is one of the most frequently studied 
metabolic processes in biology. It plays a central role in carbon metabolism, breaking 
down glucose into pyruvate that can be shunted into the citric acid cycle. The energy 
from this process is then used to drive oxidative fermentation in the mitochondria, which 
eventually uses a proton gradient in order to produce cellular energy in the form of ATP 
(Hu, Cheng, Sham, Perfect, & Kronstad, 2008). ATP provides energy for numerous 
cellular processes and is required for any organism to survive, including C. neoformans. 
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However, it has been shown that pyruvate kinase and phosphofructokinase, two enzymes 
that catalyze irreversible steps in glycolysis, are downregulated in C. neoformans cells 
grown in mammalian lung tissue (Hu et al., 2008). This is suggestive of a nutrient, and 
specifically a glucose, poor environment. Interestingly, two separate pyruvate kinase and 
hexokinase knockout strains of C. neoformans showed attenuated virulence in the murine 
inhalation model but satisfactory persistence within the lungs of the host (Price et al., 
2011). As these two enzymes function as irreversible steps in the glycolytic pathway, 
glycolysis is dispensable as a means of carbon acquisition during early pulmonary 
infection. Additionally, transcription factors known to regulate glycolysis were 
downregulated during early pulmonary infection, further corroborating this point 
(Kronstad et al., 2011).  
Alternatively, gluconeogenesis, an anabolic process that uses various forms of 
carbon in order to synthesize glucose, is upregulated (Hu et al., 2008). Gluconeogenesis 
utilizes numerous precursors depending on the availability of different carbon sources, 
though some of the most common include lactate, glycerol, and amino acids such as 
alanine and glutamine. Surfactant (predominantly phosphatidylcholine and 
phosphatidylglycerol) is also present in the mammalian lung and is a potential substrate 
for gluconeogenesis. Several different processes are used to form pyruvate from each of 
these molecules, which accumulates in the mitochondria of hepatocytes and other 
specialized cell types. In the mitochondria, pyruvate carboxylase converts pyruvate into 
oxaloacetate; a series of ten additional enzyme-catalyzed reactions then follows, leading 
to the formation of glucose. While glycolysis and gluconeogenesis are opposite metabolic 
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processes, three different enzymes in gluconeogenesis are used to catalyze the non-
reversible steps in the glycolytic pathway. One such enzyme, phosphoenolpyruvate 
carboxykinase I (PCK1) is the main regulatory step in gluconeogenesis and catalyzes the 
formation of phosphoenolpyruvate from oxaloacetate. A study looking at the differential 
expression of PCK1 transcripts between C. neoformans cells grown in mammalian lung 
tissue versus in vitro cultures showed upregulation of this enzyme during early infection 
(Hu et al., 2008). A later study showed significantly attenuated persistence in a rabbit 
model of CNS disease, further corroborating that gluconeogenesis plays a central role in 
the early pathogenesis of cryptococcal infections (Price et al., 2011).  
Use of the glyoxylate shunt during early pulmonary infection. Additionally, C. 
neoformans is able to catabolize lipids and other complex carbon compounds to use as 
alternative energy sources upon initial infection. Fluid collected from mammalian lung 
tissue by bronchoalveolar lavage is rich in phospholipids (Rooney, Young, & Mendelson, 
1994). Transcription profiling shows transiently elevated lipid and fatty acid catabolism 
genes in C. neoformans infected lung cultures when compared to CNS samples or in vitro 
lab cultures (Hu et al., 2008). Combined with the upregulation of PCK1, this suggests 
significant glucose limitation during early pulmonary infection within the host (Hu et al., 
2008).  
The glyoxylate shunt is a metabolic process similar to the citric acid cycle that 
plants, protists, and fungi use in order to generate macromolecules from alternative 
carbon sources. Specifically, this anabolic process uses a series of enzymatic reactions to 
convert 2-carbon compounds such as acetate into glucose, which can then be used for 
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various cellular functions. As acetate is one such compound that is produced in the 𝛽-
oxidation of fatty acids, the glyoxylate shunt is closely linked to the catabolism of lipids. 
Five citric acid cycle enzymes are used in this process, with the first two steps being 
identical. Acetate produced by the 𝛽-oxidation of fatty acids enters the cycle bound to the 
thiol group of CoA, where it becomes citrate, cis-aconitate, and then isocitrate. During 
the glyoxylate shunt, isocitrate is then broken down into glyoxylate and succinate by the 
enzyme isocitrate lyase. This differs from the citric acid cycle, in which isocitrate 
dehydrogenase functions to produce α-ketoglutarate while releasing one molecule of 
carbon dioxide (CO2). Both processes eventually produce oxaloacetate that can be 
converted to phosphoenolpyruvate for use in gluconeogenesis. 
 In short, the benefit of the glyoxylate shunt is that it allows an organism to 
capitalize on the 𝛽-oxidation of fatty acids via a process that bypasses the CO2 releasing 
steps in the citric acid cycle. Because carbon, and specifically carbon found in the form 
of glucose, is essential for many cellular functions, upregulation of the glyoxylate shunt 
during early pulmonary infection allows C. neoformans to produce glucose via 
gluconeogenesis without sacrificing any carbon in the form of CO2 (see Figure 1) (Hu et 
al., 2008). The glyoxylate shunt provides an efficient means of alternative carbon 
metabolism in Candida albicans and Aspergillus fumigatus that is necessary for survival 
(Lorenz & Fink, 2001; Olivas et al., 2008). However, a functional glyoxylate shunt is not 
necessary for virulence in C. neoformans, making this species unique among pathogenic 
fungi (Rude, Toffaletti, Cox & Perfect, 2002).  
Metabolism during systemic infection.  In higher eukaryotes such as mammals, 
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Figure 1. Relationship between the glyoxylate shunt and the citric acid cycle.  
By eliminating the steps of the citric acid cycle that produce CO2, the glyoxylate shunt 
allows for fatty acid catabolism without carbon loss. Adapted from “Major roles of 
isocitrate lyase and malate synthase in bacterial and fungal pathogenesis” by M. F. Dunn, 
J. A. Ramirez-Trujillo, and I. Hernandez-Lucas, 2009, Microbiology, 155(10), p. 3167.  
 
the CNS is comprised of the brain and spinal cord. Often thought of as the control center 
of the human body, the CNS is responsible for receiving incoming neuronal signals from 
the peripheral nervous system (PNS), interpreting them, and sending signals back to the 
efferent PNS in order to elicit a response. Because of its vital role in important functions 
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such as higher-order thinking, controlling reflexes, and maintaining homeostasis, the 
transport of molecules into and out of the CNS is highly regulated. This poses a new 
challenge for disseminated cryptococcal cells that have made their way from the lungs to 
the CNS, as they must adapt to yet another microenvironment in order to survive (Barelle 
et al., 2006).  
While C. neoformans faces a nutrient-poor environment upon inhalation in the 
lungs, oxygen and glucose are more abundant within the CNS and specifically within the 
brain. However, because CNS cells rapidly consume glucose and oxygen, these resources 
are not always readily accessible. Because of the high energy demand of actively 
proliferating cells, the production of ATP via oxidative phosphorylation in C. neoformans 
mitochondria is essential for survival (Ingavale et al., 2008). Indeed, isocitrate 
dehydrogenase was upregulated in a rabbit cerebrospinal fluid (CSF) model of 
cryptococcal meningitis; components of NADH dehydrogenase, cytochrome c subunits, 
and ATP synthase were also upregulated, suggesting heightened energy demand within 
the CNS (Steen et al., 2003).  
Glycolysis and gluconeogenesis. In contrast to the emphasis on gluconeogenesis 
that is seen in the murine inhalation model of early pulmonary infection, the persistence 
of C. neoformans within the CNS is largely dependent on glycolysis. Again, this was 
demonstrated using a strategic hexose kinase double-deletion strain (hxk1∆ hxk2∆), 
which blocks the entry of glucose into the glycolytic pathway (Price et al., 2011). Hexose 
kinase activity is required not only for initial infection in the lungs, but for persistence in 
the CNS as well (Price et al., 2011). Additionally, a pyruvate kinase (PYK1) knockout 
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mutant was used to block the exit of glucose from the glycolytic pathway, with the pyk1Δ 
strain exhibiting significantly reduced virulence in the rabbit CSF model. Mice infected 
with the pyk1Δ mutant survived for approximately 6 months, while those infected with 
the hxk1Δ hxk2Δ mutant survived for approximately six weeks (Price et al., 2011). Both 
strains had an impaired ability to utilize glucose, suggesting that glycolysis is the major 
player in C. neoformans’ ability to metabolize carbon once the fungus has reached the 
CNS (Price et al., 2011). Interestingly, this evidence is corroborated by a similar pattern 
of central carbon metabolism in C. albicans. A pyk1Δ strain of C. albicans showed 
significantly attenuated virulence and increased fungal burden in a murine inhalation 
model of disease, consistent with the attenuated virulence seen in the C. neoformans 
model (Barelle et al., 2006).   
While gluconeogenesis is essential for early pulmonary infection and 
dissemination of cryptococcal cells from the lungs to the CNS, a functional 
gluconeogenic pathway is not essential for persistence within the CNS itself. Researchers 
used a real-time PCR-based protocol to determine the expression of PCK1 in rabbit CSF 
versus ex vivo human CSF and in vitro C. neoformans cultures. PCK1 expression was 
elevated in the in vivo rabbit CSF model in comparison to the other samples, suggesting 
an increased rate of glucose synthesis within the CNS during cryptococcal pathogenesis. 
However, this same study created a pck1Δ knockout strain that retained its virulence 
despite lacking a functional gluconeogenic pathway. This serves to show that while 
gluconeogenesis is upregulated in the glucose-poor environment of the CSF, it is not C. 
neoformans’ primary means of utilizing alternative carbon sources during CNS infection 
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(Price et al., 2011).  
Inositol as an alternative carbon source. In addition to glucose, C. neoformans is 
able to use non-preferred carbon sources as a means of obtaining energy and performing 
cellular functions within the CNS. Inositol, a carbocyclic sugar-alcohol that is made from 
glucose, serves as the structural basis for numerous important secondary messengers such 
as inositol triphosphate. As such, this carbon-based compound is present in high 
concentrations within the human brain, where many second messengers are synthesized 
and released. Interestingly, C. neoformans upregulates inositol monophosphatase in order 
to provide an alternative means of carbon and energy acquisition in the CNS (see Figure 
2) (Steen et al., 2003). Of note, inositol production plays a direct role in intracellular 
proliferation and melanin production by C. neoformans (Luberto et al., 2001; Barnett, 
1976). 
Carbon Regulation in C. neoformans 
As previously established, the ability of C. neoformans to adapt to a wide variety of host 
microenvironments is essential for its ability to cause disease within a human host 
(Barelle et al., 2006). Specifically, this fungus has several molecular mechanisms in place 
that direct and orchestrate carbon metabolism depending on the nutrients available. In 
this way, C. neoformans is able to survive and proliferate despite environmental stress 
and change. The CCAAT-binding complex (HAP) in S. cerevisiae is a complex of four 
separate proteins (Hap2/Hap3/Hap4/Hap5) that shifts carbon metabolism from glucose 
utilization to production when environmental glucose has been depleted. This is  
Figure 2. Inositol production via inositol monophosphatase (I-1-P phosphatase).  
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Inositol monophosphatase catalyzes the conversion of inositol monophosphate to myo-
inositol, which can be used in the production of second messengers or as an alternative 
carbon source for pathogenic fungi residing within the CNS. Adapted from “Cloning and 
expression of the inositol monophosphatase gene from Methanococcus jannaschii and 
characterization of the enzyme” by L. Chen and M. F. Roberts, 1998, Applied and 
Environmental Microbiology, 64(7), p. 2610.  
 
accomplished by downregulating glycolysis and upregulating genes involved in the citric 
acid cycle and cytochrome subunits found in the electron transport chain (Nehlin, 
Carlberg, & Ronne, 1991). As Hap4 is the main regulatory subunit in the Hap Complex 
of S. cerevisiae, an orthologous HapX, was identified in C. neoformans (Caza, Hu, Price, 
Perfect, & Kronstad, 2016). 
MIG 
Mig1, a transcription factor initially found in S. cerevisiae, is a well-studied zinc 
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finger protein known for its role as a global catabolite repressor. As Mig1p is expressed 
at high levels when glucose is abundant, the Mig1p complex represses genes involved in 
alternative carbon acquisition and metabolism. In doing so, Mig1p ensures that glucose is 
used as the primary carbon source when available. Of note, additional data suggests that 
Mig1p negatively affects the expression of oxidative phosphorylation and iron transport 
proteins in glucose-limited environments (Pir et al., 2008). A Mig1p ortholog was 
identified in C. neoformans, with the new candidate gene identified as MIG1. It is 
interesting to note that the regulatory Hap4p subunit in S. cerevisiae acts as a 
transcriptional activator of MIG1 while the C. neoformans ortholog, HapX, functions to 
repress transcription. Though genome analysis showed lower than expected nucleotide 
conservation between this gene in S. cerevisiae and C. neoformans, the zinc-finger 
domain of the protein was highly conserved (Price et al., 2016). Several different 
methods were employed to compare the two orthologs, which showed highly conserved 
functional properties between the two organisms.  
A MIG1 deletion mutant strain (mig1Δ) was then analyzed via microarray 
analysis in an effort to determine the effects of MIG1 on the transcriptome of C. 
neoformans (Caza et al., 2016). As expected, mig1Δ cells exhibited increased expression 
of genes involved in alternative carbon metabolism when compared to wild type (WT). 
Interestingly, differential expression was also noted between cells growing on iron-rich 
and iron-poor media, suggesting a possible link between MIG1 function and iron 
availability. Further experimentation linked a functional MIG1 gene to reactive oxygen 
species (ROS) resistance, particularly in cultures grown at 37°C (Caza et al., 2016). This 
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is important to note, as the temperature of the human body generally ranges from 36.1°C 
to 37.2°C.  
A mig1Δ strain of C. neoformans showed relatively unaffected persistence in a 
murine macrophage model (Caza et al., 2016). Both the mig1Δ strain and the hapxΔ 
strain showed comparable fungal burden in lung tissue when compared to WT cells. 
However, when lacking both MIG1 and HAPX functions, survival was noticeably 
decreased, and fungal burden was markedly smaller than WT or mig1Δ cells in all 
examined tissue types except the brain. This data indicates that the interaction between 
the Hap complex, specifically the HapX subunit, and Mig1 is essential for nutrient 
sensing and virulence in the pathogenesis of cryptococcus. Importantly, a MIG1 deletion 
in C. neoformans has been directly linked with increased susceptibility to antifungal 
compounds such as fluconazole and tetracycline, the current front-line treatments for 
cryptococcal infections. As such, MIG1 has been identified as a potential drug target. A 
strategic drug targeting MIG1, when given in conjunction with current treatments such a 
fluconazole and tetracycline, could positively impact the effectiveness of current 
treatment options.  
SNF1 
 While Mig1 plays a crucial role in enforcing the preferential use of glucose when 
available, Snf1 is a well-characterized protein in S. cerevisiae that has an orthologous 
predicted gene (SNF1) in C. neoformans. As a serine-threonine protein kinase, Snf1 
selectively phosphorylates serine or threonine residues on its specific substrates; in this 
way, Snf1 reverses the glucose-dependent repression of genes involved in the metabolism 
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of secondary carbon sources (see Figure 3). This allows C. neoformans to metabolize 
alternate carbon sources when necessary, such as in the glucose-poor environment of the 
mammalian lung upon initial infection. Carbon metabolism is a complex and integrated 
process, and the glucose-sensing function of the Snf1/AMPK pathway plays a role in 
regulating the opposing functions of Mig1. As mentioned previously, the Mig1 system is  
 
activated in a glucose-rich environment, and alternatively the Snf1/AMPK pathway is 
activated in nutrient-poor settings (Caza et al., 2016).  
A deletion of the SNF1 gene in C. neoformans yielded interesting results. Melanin 
production was significantly impaired, virulence was decreased, and alternative carbon 
source utilization was altered. As capsule production is dependent on carbon usage, 
regulation of this essential virulence factor was also disrupted. Cryptococcal cells were 
still able to disseminate to the CNS, though they were not able to survive for extended 
periods of time once they arrived (Yang et al., 2010).  
A SNF1 targeted knockout strain (snf1Δ) was created that showed significantly 
decreased virulence when compared to the WT strain of C. neoformans. After being 
injected with snf1Δ, mice had a median survival of 72 days. This was significantly longer 
than the 20-day median survival time of mice injected with WT C. neoformans (Yang et 
al., 2010). A large volume of data suggests that both Mig1 and Snf1 are essential for 
carbon acquisition and metabolism in the pathogenesis of cryptococcosis. By guiding the 
use of glucose and alternative carbon sources, these two proteins allow C. neoformans to 
survive and proliferate in a wide array of microenvironments.  
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Figure 3. The SNF1/AMPK pathway regulates alternative carbon usage.    
When glucose is limited, the SNF1/AMPK pathway is used to upregulate the expression 
of genes involved in alternative carbon source metabolism. Alternatively, when glucose 
is available, these same genes are repressed so that the cell can preferentially metabolize 
glucose. Adapted from “SNF1/AMPK/SnRK1 kinases, global regulators at the heart of 
energy control?” by C. Polge and M. Thomas, 2007, Trends in Plant Science, 12(1), p. 
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Polysaccharide Capsule 
In addition to playing a role in numerous normal cellular functions, glucose 
metabolism is essential for the creation of C. neoformans’ characteristic polysaccharide 
capsule. The capsule is the best studied and most significant virulence factor in this 
pathogenic fungus, and it can grow to a width that is several times the cell’s diameter 
(See Figure 4; Srikanta, Santiago-Tirado, & Doering, 2014). It also has antiphagocytic 
properties that prevent the host organism’s immune system from recognizing its presence, 
providing an additional obstacle for clinicians and scientists working to treat cryptococcal 
infections (Srikanta, Yang, Williams, & Doering, 2011). Additionally, the dynamic 
nature of this capsule helps C. neoformans to evade human immune cells (O’Meara et al., 
2010).  
The capsule is primarily made of two virulent polysaccharides: 
glucuronoxylomannan (GXM) and glucuronoxylomannogalactan (GXMGal) (Wang et 
al., 1995). The monomers are synthesized in the cytoplasm of the cell before they are 
transported close to the cell surface and formed into long polymers. These polymers are 
then transported through the cell wall via vesicular transport before they are attached. 
Additional polymerization can occur outside the cell if the fungus is exposed to inducing 
conditions. GXM is a large polysaccharide comprised of mainly UDP-mannose subunits 
and accounts for approximately ninety percent of the capsule. In contrast, the major 
structural subunit of GXMGal is UDP-galactose. In addition to UDP-mannose and UDP- 
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Figure 4. The polysaccharide capsule is a virulence factor of C. neoformans.    
The polysaccharide capsule of C. neoformans grows to several times the cell’s diameter 
and is essential for virulence. This image depicts JEC21, a strain of C. neoformans, after 
exposure to urea as a nitrogen source. Staining with India Ink is a technique commonly 
used to visualize the large capsule, as is seen in this image (Personal communication, M. 
S. Price, October 23, 2019).  
 
galactose, UDP-glucuronic acid and UDP-xylose are necessary components of the 
carbohydrate backbone. Each simple sugar is covalently attached as the polymerization 
process occurs. Once the backbone structure is complete, it is modified with unique 
moieties that ensure proper folding and branching (O’Meara & Alspaugh, 2012).  
Once specific moieties are added, the capsule is further modified by a variety of 
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different mechanisms. O-acetylation via the enzyme Cas1 glycosyltransferase occurs 
exclusively at the mannose and glucuronylated mannose residues (Janbon, Himmelreich, 
Moyrand, Improvisi, & Dromer, 2001). While their exact function is still under 
investigation, Pbx1 and Pbx2 are two B-helix proteins that modify the backbone by 
incorporating glucose residues (Liu, Kelly, Chow, & Madhani, 2007). Additionally, the 
Csp1 protein is responsible for synthesizing hyaluronic acid, a structural component of 
the capsule that allows C. neoformans to cross the blood brain barrier via facilitated 
transport. While the exact regulatory mechanism remains unclear, cells that lack 
hyaluronic acid have a decreased capsule diameter and an altered structure (O’Meara & 
Alspaugh, 2012; Jong et al., 2007). As dissemination of fungal cells and the ability to 
cause meningitis is dependent on C. neoformans’ ability to enter the CNS, proper capsule 
synthesis is essential for virulence.  
Interestingly, studies have shown that while C. neoformans is surrounded by a 
large polysaccharide capsule when taken from in vivo samples, in vitro cultures show 
varying degrees of encapsulation (Granger, Perfect, & Durack, 1985). Similarly, this 
fungus has the ability to alter the composition of its capsule depending on the 
microenvironment that it is in, and induction of capsule synthesis is often started upon 
entry into the host organism (O’Meara & Alspaugh, 2012). Once synthesis is induced, the 
capsule structure remains dynamic as it travels through the host. This dynamic nature of 
C. neoformans allows it to adapt in various organs such as the lungs and brain, which can 
be seen by the heterogeneous nature of capsules observed from a variety of organs 
(McFadden, Fries, Wang, & Casadevall, 2007). Additionally, biochemical analysis via 
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mass spectrometry and NMR showed variable side chain composition of GXM and 
GXMGal that allowed variable antibody binding depending on the environment. A 
variety of studies have been performed to better understand the biochemical regulation of 
capsule synthesis. While it is a very complex process that is still under investigation, 
several environmental parameters have been identified: iron concentration, CO2 levels, 
ambient pH, glucose availability, and nitrogen availability (O’Meara & Alspaugh, 2012). 
When the cell encounters a less than favorable level of any of these parameters, capsule 
production is induced.  
Studies have shown that mutated strains that are unable to produce a capsule are 
avirulent, confirming that the polysaccharide capsule is essential to the pathogen’s 
survival in a host (Wilder, Olson, Chang, Kwon-Chung, & Lipscomb, 2002). This has 
important implications for clinical management, as a capsule inhibitor could serve as a 
targeted drug therapy when treating this disease.  
It is important to note that the capsule of C. neoformans currently serves as an 
important diagnostic tool. Effective treatment of C. neoformans depends on early 
detection and diagnosis, which can be achieved via a highly sensitive antigen test that 
recognizes common capsule serotypes. Additionally, an India-ink stain can be used to 
identify encapsulated cells from a sputum culture or from bronchoalveolar lavage fluid. 
Conclusion 
Cryptococcosis, infection resulting from the C. neoformans species complex, kills 
thousands of immunosuppressed individuals annually. While the majority of these 
patients have end stage HIV/AIDS, other susceptible populations include transplant 
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patients on immunosuppressive drugs, cancer patients, and individuals with autoimmune 
disorders. Severity of the disease can range from localized cutaneous cryptococcus to 
widespread systemic infection with CNS involvement. Despite aggressive antifungal 
therapy, the prognosis of patients with C. neoformans infections continues to be poor; 
survival rates hover around fifty percent in patients with systemic disease, even in 
western countries where patients have access to sophisticated healthcare. Nutrient 
acquisition, and specifically carbon metabolism, is essential for C. neoformans 
persistence and proliferation in the host. Additionally, carbon is the main structural 
component in the polysaccharide capsule, the most well studied and arguably most 
important virulence factor of this devastating fungus. While treatments such as 
fluconazole do exist, they are expensive and only somewhat effective at treating late-
stage and disseminated disease. As such, better understanding the relationship between 
carbon metabolism and virulence is critical to the development of new targeted drug 
therapies in the near future.  
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